We established a subclone, SHOK, from the GHE-L cell line, an immortal line derived from a primary culture of Syrian hamster embryo cells, as a recipient cell line useful for the detection of oncogenes by transfection. SHOK cells were almost as susceptible as NIH 3T3 cells to focus formation by many oncogenes, including v-raf, v-Ha-ras, vKi-ras, or activated c-Ha-ras. The susceptibility of SHOK to focus formation was higher than that of NIH 3T3 for v-mos but was lower for v-fps, v-fgr, v-src, v-sis, and v-abl. When DNAs extracted from 27 human and murine tumors were tested for focus formation, 5 DNAs were positive in NIH 3T3 cells, whereas 9 were positive in SHOK cells at the primary transfection. Using SHOK cells as recipients of tumor cellular DNA, we isolated another oncogene and a c-Ki-ras2 gene mutated at codon 146 that were difficult to detect in NIH 3T3 cells. SHOK cells have a low rate of spontaneous transformation, produce easily distinguishable foci, and maintain a stable karyotype in transformed cells. In addition to being useful for the screening of human tumor DNAs, SHOK cells will be useful for the isolation of oncogenes from murine tumors because of their hamster origin.
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Development of transfection methods for DNA of high molecular weight into mammalian cells (1) has made possible the isolation of many cellular functional genes, including activated cellular oncogenes (2, 3) . As recipient cells for assays of cellular-transforming genes, NIH 3T3 cells have been widely used, mainly because of their high susceptibility to transformation. In general, however, the expression of the transfected genes is affected by genetic and physiological conditions of the recipient cells. For example, with viral oncogenes v-myc or v-myb, it is likely that the transforming activities of some cellular genes are unexpressed or suppressed in NIH 3T3 cells and that their expression becomes apparent in other cells with different regulations of gene expression or different metabolic functions. A recipient cell line that could be used to detect such transforming genes would be of use.
The role of the activation of cellular oncogenes in carcinogenesis has been analyzed by experimental animal models of carcinogenesis; most of such models have used mice. However, it has been difficult to identify transforming genes in mice tumor cells when not focusing on oncogenes already characterized because species-specific sequences that are dispersed and much repeated in mammalian genomes (4, 5) were used as molecular markers to distinguish transfected DNA from host DNA. Thus, the development of recipient cell lines of species other than mice should help elucidate the activation of protooncogenes in mouse carcinogenesis.
Though several rodent cell lines other than NIH 3T3 are used as recipient cells for detecting cellular oncogenes, these lines had few advantages over NIH 3T3 cell use (6, 7) .
Here, we report the development of a hamster cell line for detecting cellular oncogenes.
MATERIALS AND METHODS
Cell Lines and Media. The GHE-L cell line was established with a culture of high cell density from a primary culture of Syrian hamster embryo after 50 passages (F.S., unpublished work) at a density of 2 x 106 cells per 50 cm2 every 8 days. The SHOK cell line was subcloned from the GHE-L cells. These cells were maintained at low cell densities in Dulbecco's modified Eagle's minimum essential medium (DMEM) supplemented with 10%o fetal calf serum (FCS). For the focus assay, DMEM supplemented with 3% FCS was used. A subclone from the NIH 3T3 cell line was selected for its flat morphology and low incidence of spontaneous transformation. NIH 3T3 cells were maintained in DMEM supplemented with 10% calf serum. For focus assay of NIH 3T3 cells, DMEM supplemented with 5% calf serum was used.
Preparation and Sources of DNAs. Cellular DNAs of high molecular weight (8) (4) . To isolate the cDNA of the transforming gene, we extracted and purified mRNA from the same transformants as described (9) . We constructed a cDNA library from the mRNA using a cDNA cloning kit (Amersham) and screened the cDNA library with some genomic fragments of the transforming gene as probes.
To clone the activated Ki-ras gene from HuT-14 DNA, we constructed A2001 libraries by inserting EcoRI or HindIII partial digests of DNA from secondary transformants and screened the libraries with Alu sequence as probe. We also screened a cDNA library from the secondary transformants with probes specific for human Ki-ras gene.
To construct cDNA expression vectors, we removed the 3-kilobase pair (kbp) Kpn I fragment specific for v-fgr from the plasmid pSV2neo-fgr and inserted cDNAs into the Kpn I site between the long terminal repeats of Gardner-Rasheed feline sarcoma virus.
RESULTS
Subcloning of the Hamster Cell Line SHOK from GHE-L Cells. GHE-L cells formed transformed foci by transfection with pT22 (T24-c-Ha-rasl gene; F.S., unpublished work). The transforming efficiency of GHE-L cells was lower than that of NIH 3T3 cells, and it was sometimes difficult to distinguish authentic foci from pseudofoci in GHE-L cells because of their heterogeneity. To use GHE-L cells as a recipient for the detection of cellular oncogenes, we subcloned the cells and found one subclone with transforming efficiency by pT22 and transfection efficiency of G418 resistance gene almost equal to those of NIH 3T3 cells (data not shown). We named the subclone SHOK for Syrian hamster cells Osaka-Kanazawa and examined its use as a recipient for oncogenes.
Comparison of Focus-Forming Efficiencies Between SHOK and NIH 3T3 Cells. Table 1 shows the results of transfection assays of various oncogenes. Oncogenes could be classified into four groups by means of focus-forming abilities with SHOK and NIH 3T3 cells. SHOK cells were more efficiently transformed by plasmid pMSV-1L and pSV2-v-mos than were NIH 3T3 cells. These are v-mos genes under the control of different promoters, so the SHOK cells seemed to be more sensitive to transformation by the v-mos gene than were the NIH 3T3 cells. However, SHOK cells were transformed at lower efficiency by v-fgr, v-src, v-sis, v-abl, and v-fps. Both cells had similar transforming efficiencies (<3-fold) by v-raf, v-Ki-ras, v-Ha-ras, and activated c-Ha-ras, and formed no foci with c-myc, proviral DNA ofavian erythroblastosis virus (pAE-11), or proviral DNA of avian myeloblastosis virus (AllA1-1).
Detection and Identification of Transforming Genes Derived from Tumor DNAs. We tested the 27 tumor DNAs listed above for their focus-forming activities in SHOK and NIH 3T3 cells. DNAs extracted from cells transformed by tumor DNAs were analyzed by Southern blot hybridization with the repetitive sequences as probes (see Fig. 2 A-C) and put through the secondary transfection assays. Transformant DNAs derived from the 11 tumor DNAs listed in Table 2 , except for N5-BMX-2596, contained human or murine repetitive sequences and formed foci in the secondary transfection assays. A few transformants did not contain repetitive sequences and did not form foci at the secondary transfection, Southern blot analysis showed that most transforming genes of the tumor DNAs were members of the ras gene family (HuT-14, CC-014, CT-6, CT-8, CT-10, CT-13, and N5-2057), but the transforming genes of TCO-4, CT-12, and N5-BMX-3013 DNAs were not ras-family members. With N5-2057 DNA, one transformant contained an activated mos gene, whereas the other transformants contained an activated Ki-ras gene, and the DNAs of both transformants had focus-forming activities in SHOK and NIH 3T3 cells.
Properties of SHOK Cells and the Transformed Cells.
SHOK cells and the cells transformed by DNAs of T24,
HuT-14, and TCO-4 were examined for properties ( 
In SHOK cells, the incidence of spontaneous transformation was low (0.07 per dish) and increased with repeated passages. The transformed foci were easy to identify, and transformation was almost linearly dose-dependent within the range of 5-100 focus-forming units per dish.
Transforming Genes from TCO4 DNA and HuT-14 DNA. DNAs of the SHOK cells transformed with TCO-4 DNA and DNAs of the tertiary transformants contained Alu sequences ( Fig. 2A) , and the transforming gene was not Ha-ras, Ki-ras, N-ras, raf, or mos, according to the results of Southern blot analysis. We isolated the genomic transforming sequence and its cDNA from the tertiary transformants. The physical map of the transforming sequence was not identical to that of Ha-ras, Ki-ras, N-ras, mel, dbl, ret, raf, trk, hst, ica, met, mcf-J, mcf-2, or the thyroid cancer-associated oncogene (3, 18, 19) , and the cDNA did not hybridize with v-src, v-fgr, v-fps, v-fes, v-ros, v-erbB, v-raf, v-Ha-ras, v-Ki-ras, v-erbA, c-erbB-2, B-lym-1, v-yes, v-abl, v-fms, v-mos, N-ras, v-myc, v-fos, v-myb, v-rel, v-sis, N-myc, or L-myc by Southern blot analysis. According to the results of computer analysis, the cDNA also lacked homology to reported genes. These results suggested that the transforming gene of TCO-4 DNA was another oncogene.
Even the secondary transformants with HuT-14 DNA contained human c-Ki-ras gene (Fig. 2D) , so the transforming gene of HuT-14 DNA was likely to be Ki-ras gene. This finding was of interest because NIH 3T3 cells formed no foci by transfection with HuT-14 DNA in repeated experiments, and no tumors positive for Alu sequence were found in tumorigenicity assays with NIH 3T3 cells used as recipients (20) . To study the mechanism involved in the activation ofthe Ki-ras gene, we analyzed its genomic and cDNA sequences and found a point mutation at codon 146 that substituted the residue proline for alanine. Mutation of this position of ras genes has not been reported in NIH 3T3 assays.
Focus-Forming Activities ofTransforming Genes. As human c-Ki-ras2 gene is '40 kbp long and the transforming gene from TCO-4 DNA was >30 kbp long, it was difficult to isolate biologically active genomic clones of these oncogenes. Thus, to investigate the transforming activities of transforming genes from and TCO-4 DNA, we constructed cDNA expression plasmids (Table 4) . pJJ26, a cDNA expression plasmid of the transforming gene from TCO-4 and pLTRKras(Prol46), a cDNA expression plasmid of c-Ki-ras2 gene from HuT-14, had focus-forming activities both in SHOK and NIH 3T3 cells. In NIH 3T3 cells, pLTRKras(Prol46) had -5-fold lower focus-forming activity than pLTRKras(Vall2), an expression plasmid of human c-Ki-ras2 mutated at codon 12. However, both Ki-ras expression plasmids had similar focus-forming activities in SHOK cells.
DISCUSSION
The NIH 3T3 cell line has been much used as recipient cells for the detection of oncogenes. Some rodent cells are transformed by transfection with oncogenes, but only a fewRat-2 (6) and C3H10TA/2 (7)-have been employed as recipient cells for the detection of cellular oncogenes. Most of these lines proved lower in transforming efficiency than NIH 3T3 cell line (6) and more difficult to use. C3H1OT'/2 cells are transformed efficiently (7) , but they do not detect any oncogenes other than those that transform NIH 3T3 cells. To Our results suggest that the SHOK cell line will be useful for studies of oncogenes and the cellular factors affecting oncogene functions. Of course, many oncogenes will escape detection by either SHOK or NIH 3T3 cells, and screening systems must be devised for such oncogenes.
